Cargando…

Garlic as a Lipid Lowering Agent—A Meta-Analysis

Garlic supplements may have an important role to play in the treatment of hypercholesterolaemia. To determine the effect of garlic on serum lipids and lipoproteins relative to placebo and other lipid lowering agents, a systematic review, including meta-analysis, was undertaken of published and unpub...

Descripción completa

Detalles Bibliográficos
Autores principales: Silagy, Christopher, Neil, Andrew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Royal College of Physicians of London 1994
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5400934/
https://www.ncbi.nlm.nih.gov/pubmed/8169881
_version_ 1783230933707522048
author Silagy, Christopher
Neil, Andrew
author_facet Silagy, Christopher
Neil, Andrew
author_sort Silagy, Christopher
collection PubMed
description Garlic supplements may have an important role to play in the treatment of hypercholesterolaemia. To determine the effect of garlic on serum lipids and lipoproteins relative to placebo and other lipid lowering agents, a systematic review, including meta-analysis, was undertaken of published and unpublished randomised controlled trials of garlic preparations of at least four weeks' duration. Studies were identified by a search of MEDLINE and the ALTERNATIVE MEDICINE electronic databases, from references listed in primary and review articles, and through direct contact with garlic manufacturers. Sixteen trials, with data from 952 subjects, were included in the analyses. Many of the trials had methodological shortcomings. The pooled mean difference in the absolute change (from baseline to final measurement in mmol/l) of total serum cholesterol, triglycerides, and high-density lipoprotein (HDL)-cholesterol was compared between subjects treated with garlic therapy against those treated with placebo or other agents. The mean difference in reduction of total cholesterol between garlic-treated subjects and those receiving placebo (or avoiding garlic in their diet) was –0.77 mmol/l (95% CI: –0.65, –0.89 mmol/l). These changes represent a 12% reduction with garlic therapy beyond the final levels achieved with placebo alone. The reduction was evident after one month of therapy and persisted for at least six months. In the dried garlic powders, in which the allicin content is standardised, there was no significant difference in the size of the reduction across the dose range of 600–900 mg daily. Dried garlic powder preparations also significantly lowered serum triglyceride by 0.31 mmol/l compared to placebo (95% CI: –0.14, –0.49). HDL-cholesterol was non-significantly lowered by 0.04 mmol/l (95% CI: –0.11, 0.03 mmol/l). Side-effects from garlic therapy, other than odour, were rare. In conclusion, use of garlic therapy, either as dried garlic preparations (in doses as low as 600 mg per day) or as fresh, high allicin yielding garlic (10–20 g per day) appears significantly to reduce total serum cholesterol over a 1–3 months period. However, more rigorously designed and analysed trials are needed.
format Online
Article
Text
id pubmed-5400934
institution National Center for Biotechnology Information
language English
publishDate 1994
publisher Royal College of Physicians of London
record_format MEDLINE/PubMed
spelling pubmed-54009342019-01-22 Garlic as a Lipid Lowering Agent—A Meta-Analysis Silagy, Christopher Neil, Andrew J R Coll Physicians Lond Original Papers Garlic supplements may have an important role to play in the treatment of hypercholesterolaemia. To determine the effect of garlic on serum lipids and lipoproteins relative to placebo and other lipid lowering agents, a systematic review, including meta-analysis, was undertaken of published and unpublished randomised controlled trials of garlic preparations of at least four weeks' duration. Studies were identified by a search of MEDLINE and the ALTERNATIVE MEDICINE electronic databases, from references listed in primary and review articles, and through direct contact with garlic manufacturers. Sixteen trials, with data from 952 subjects, were included in the analyses. Many of the trials had methodological shortcomings. The pooled mean difference in the absolute change (from baseline to final measurement in mmol/l) of total serum cholesterol, triglycerides, and high-density lipoprotein (HDL)-cholesterol was compared between subjects treated with garlic therapy against those treated with placebo or other agents. The mean difference in reduction of total cholesterol between garlic-treated subjects and those receiving placebo (or avoiding garlic in their diet) was –0.77 mmol/l (95% CI: –0.65, –0.89 mmol/l). These changes represent a 12% reduction with garlic therapy beyond the final levels achieved with placebo alone. The reduction was evident after one month of therapy and persisted for at least six months. In the dried garlic powders, in which the allicin content is standardised, there was no significant difference in the size of the reduction across the dose range of 600–900 mg daily. Dried garlic powder preparations also significantly lowered serum triglyceride by 0.31 mmol/l compared to placebo (95% CI: –0.14, –0.49). HDL-cholesterol was non-significantly lowered by 0.04 mmol/l (95% CI: –0.11, 0.03 mmol/l). Side-effects from garlic therapy, other than odour, were rare. In conclusion, use of garlic therapy, either as dried garlic preparations (in doses as low as 600 mg per day) or as fresh, high allicin yielding garlic (10–20 g per day) appears significantly to reduce total serum cholesterol over a 1–3 months period. However, more rigorously designed and analysed trials are needed. Royal College of Physicians of London 1994 /pmc/articles/PMC5400934/ /pubmed/8169881 Text en © Journal of the Royal College of Physicians of London 1994 http://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) , which permits non-commercial use and redistribution provided that the original author and source are credited.
spellingShingle Original Papers
Silagy, Christopher
Neil, Andrew
Garlic as a Lipid Lowering Agent—A Meta-Analysis
title Garlic as a Lipid Lowering Agent—A Meta-Analysis
title_full Garlic as a Lipid Lowering Agent—A Meta-Analysis
title_fullStr Garlic as a Lipid Lowering Agent—A Meta-Analysis
title_full_unstemmed Garlic as a Lipid Lowering Agent—A Meta-Analysis
title_short Garlic as a Lipid Lowering Agent—A Meta-Analysis
title_sort garlic as a lipid lowering agent—a meta-analysis
topic Original Papers
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5400934/
https://www.ncbi.nlm.nih.gov/pubmed/8169881
work_keys_str_mv AT silagychristopher garlicasalipidloweringagentametaanalysis
AT neilandrew garlicasalipidloweringagentametaanalysis